Global CRO Market 2015-2019

Published: Dec 2014
Pages: 75
SKU: IRTNTR4915

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version!

About CRO
Organizations that support outsourced research services for the Pharmaceutical, Biotechnology, and Medical Devices industries are called CROs. The nature of engagement of outsourced services is generally on contractual basis. This helps the vendors to control their R&D expenditure and concentrate on their core skills. CROs help vendors expand their capacities from clinical trials to healthcare regulatory submissions, biostatistics, and data management work. Furthermore, CROs have also started offering services at all phases (pre-clinical, phase I, phases II & IIIa, phases IIIb & IV, labs, and others) of drug development and discovery. CROs have built their capabilities from the earliest to the latest stages of drug development with emphasis on partnership, collaboration, and fee for service models.
Technavio's analysts forecast the Global CRO market growth at a CAGR of 9.83 percent over the period 2014-2019.

Covered in this Report
The CRO market size can be divided into two segments: early-stage development services and late-stage development cervices. To calculate the CRO market size, the report considers the revenue generated from the sales of outsourcing of R&D services to CROs by global pharmaceutical and biopharmaceutical vendors.
Technavio's report, Global CRO Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the global CRO market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
• Americas
• APAC
• EMEA

Key Vendors
• Covance
• Parexel International
• PRA Health Sciences
• Quintiles Translational

Market Driver
• Increased Outsourcing of R&D Activities
• For a full, detailed list, view our report

Market Challenge
• Shortage of CRO Staff
• For a full, detailed list, view our report

Market Trend
• Increase in Number of M&A
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving the CRO market growth?
• What are the challenges to CRO market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Type of Service
07.1 Global Early Stage Development Services Market
07.1.1 Market Size and Forecast
07.2 Global Late Stage Development Services Market
07.2.1 Market Size and Forecast
08. Market Segmentation by Therapeutic Area
09. Geographical Segmentation
09.1 CRO Market in Americas
09.1.1 CRO Market in the US
09.2 CRO Market in EMEA Region
09.3 CRO Market in APAC Region
09.3.1 CRO Market in China
09.3.2 CRO Market in India
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Covance Inc.
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue 2013
18.1.4 Product Portfolio by Revenue 2013
18.1.5 Business Segmentation by Revenue 2012 and 2013
18.1.6 Geographical Segmentation by Revenue 2013
18.1.7 Business Strategy
18.1.8 Recent Developments
18.1.9 SWOT Analysis
18.2 Quintiles Translational Corp.
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2013
18.2.4 Product Portfolio by Revenue 2013
18.2.5 Business Segmentation by Revenue 2012 and 2013
18.2.6 Geographical Segmentation by Revenue 2013
18.2.7 Business Strategy
18.2.8 Recent Developments
18.2.9 SWOT Analysis
18.3 Parexel International Corp.
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Product Portfolio by Revenue 2013
18.3.5 Business Segmentation by Revenue 2012 and 2013
18.3.6 Geographical Segmentation by Revenue 2013
18.3.7 Business Strategy
18.3.8 Recent Developments
18.3.9 SWOT Analysis
18.4 PRA Health Sciences Inc.
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2013
18.4.4 Product Portfolio by Revenue 2013
18.4.5 Business Segmentation by Revenue 2012 and 2013
18.4.6 Geographical Segmentation by Revenue 2013
18.4.7 Business Strategy
18.4.8 Recent Developments
18.4.9 SWOT Analysis
19. Other Reports in this Series

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES